Skip to content
ES
MARKETS / NASDAQ / OPCH
NASDAQ · SERVICES-HOME HEALTH CARE SERVICES · LARGE CAP

Option Care Health, Inc. OPCH

18 fiscal years on record · USD · FY2025 reported · SEC filings only
$5.6B
▲ 13.0% YoY
$207.6M
▼ 2.0% YoY
$217.1M
▼ 24.5% YoY
In brief

What this company does

Option Care Health contracts with managed care organizations, third-party payers, hospitals, physicians and other referral sources to provide pharmaceuticals and complex compounded solutions to patients for intravenous delivery in the patients' homes or other nonhospital settings. It operates a national network of 196 locations in 43 states. The company operates in one segment, infusion services. Its multidisciplinary team of more than 5,000 clinicians, including pharmacists, pharmacy technicians, nurses and dietitians, provides infusion service coverage for nearly all patients across the United States needing treatment for complex and chronic medical conditions. For the year ended December 31, 2025, approximately 68% of its pharmaceutical and medical supply purchases were from four vendors. Following the close of the Merger, BioScrip was rebranded as Option Care Health, Inc.

Written from the business description in OPTION CARE HEALTH, INC.'s annual report to the U.S. Securities and Exchange Commission, filed 24 February 2026. Every sentence was checked against that document before publication.

Growth
USD 5.6B
Revenue, FY2025 · full 18-year series below
Revenue $B Net income $B
FY2025 · Revenue 5.6 · Net income 0.2
2B4B2007201120142017202020232025
Compound annual growth
+12.7%
+13.3%
+19.1%
+11.3%
+15.2%
3 yrs
5 yrs
10 yrs
15 yrs

Revenue compounded at +13.3% a year over five years.

Compound annual rates per period — left blank where that exact year isn't on file, the series crosses a loss, or (per-share rows) a split falls inside the window.

Profitability
4 cents
of every revenue dollar became profit
Operating margin Net margin
FY2025 · Operating 6.0% · Net 3.7%
5%10%-10%-20%-30%2007201120142017202020232025
ROE
FY2025 · ROE 15.2%
-200%-400%2007201120142017202020232025
Gross margin19.3%
Operating margin6.0%
Net margin3.7%
Return on assets6.0%
EBITDAUSD 405.4M

Each USD of equity produced 15 cents of profit this year.

Cash & shareholders
USD 310.0M
returned in FY2025 · dividends + net buybacks
Free cash flow $M
FY2025 · FCF 217.1
200M-200M2007201120142017202020232025
Net buybacks $M Dividends $M
FY2025 · Dividends — · Net buybacks 310.0
200M20212022202320242025
Dividends paid—
Net buybacksUSD 310.0M
Share of profit149.3%
Consecutive raises—

USD 310.0M in buybacks — 149% of the year's profit, so the payout drew on cash built up earlier.

Total assetsUSD 3.5B
EquityUSD 1.3B
CashUSD 232.6M
Gross debtUSD 1.2B
Net debtUSD 928.2M
Current ratio1.53×

Net debt stands at 70% of equity.

The 18-year record
18 fiscal years
Every figure from documents filed with the SEC · USD

EPS, diluted, dividend per share and shares outstanding are shown without shading, and a vertical line marks the year the share count changed — the series crosses a large, unexplained change in share count, so the years on either side are not on a comparable scale.

row low → row highnegative
Metric 202520242023202220212020201920182017201620152014201320122011200920082007
Revenue $B5.65.04.33.93.43.02.31.91.80.91.00.90.70.60.61.31.41.2
Operating income $B0.30.30.30.20.20.1−0.00.00.0−0.0−0.3−0.1−0.00.00.00.0−0.10.0
EBITDA $B0.40.40.40.30.30.20.10.10.10.0−0.3−0.1−0.00.00.00.0−0.10.0
Income tax $B0.10.10.10.1−0.00.0−0.0−0.0−0.00.0−0.00.00.0−0.00.0−0.0−0.00.0
Net income $B0.20.20.30.20.1−0.0−0.1−0.00.0−0.0−0.3−0.1−0.10.10.00.1−0.10.0
Free cash flow $B0.20.30.30.20.20.10.0−0.00.0···−0.3−0.00.00.0··
EPS, diluted $1.271.231.480.830.77−0.04−0.49−0.040.03−0.55−4.51−2.15−1.081.150.141.36−1.930.09
Dividend / sh $··················
Payout %··················
ROE %15.215.019.011.812.8−0.8−10.1−1.00.6−16.5−444.4−51.6−21.525.43.743.1−56.62.0
Shares out B0.160.170.170.180.180.180.180.140.130.120.070.070.070.060.060.040.04·

Slide the table for earlier years · "·" marks a figure not available in our data for that year.

Provenance
Company facts, as filed
How we verify · 0 failures in 88 reconciliationsAUDITED

Reconciled in 18 of 19 fiscal years. 7 checks could not be computed.

EPS recomputationBalance-sheet identityGross profitBalance-sheet liquiditymoeda_consistente0 failures
ActivityServices-Home Health Care Services
Listed onNASDAQ
Incorporated inDelaware
Fiscal year endsDecember 31
Data on record since2007

Share this section

Download image